- |||||||||| Review, Journal: Sarcopenia as a risk factor for hypertension. (Pubmed Central) - Dec 5, 2024
It also attributes to cardiovascular risk reduction and prevention of falls. In this review article, we summarize latest issues about sarcopenia and exercise.
- |||||||||| Journal: Identifying risk factors for pre-sarcopenia in early middle-age. (Pubmed Central) - Dec 5, 2024
A higher likelihood of presarcopenia was associated with sex-specific lower self-perceived physical fitness. These modifiable biomarkers may serve as targets for clinical screening and early intervention aimed at slowing or preventing progression to sarcopenia in old age.
- |||||||||| Review, Journal: Diet and physical exercise in elderly people with obesity: The state of the art. (Pubmed Central) - Dec 5, 2024
Therefore, this review provides the state of the art on scientific knowledge regarding the main effects of an adequate nutritional plan and an individualised exercise prescription on the general health of elderly with obesity. In particular, this paper addresses the effect of nutrition and physical exercise on pathophysiological changes peculiar of ageing and obesity, providing also the scientific rational for nutritional and exercise prescription in the population.
- |||||||||| Retrospective data, Review, Journal: Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis. (Pubmed Central) - Dec 5, 2024
In particular, this paper addresses the effect of nutrition and physical exercise on pathophysiological changes peculiar of ageing and obesity, providing also the scientific rational for nutritional and exercise prescription in the population. These meta-analyses suggest that sarcopenia, no matter observed before or after tumor resection, is associated with worse OS and DFS in patients with CRC who have no distant metastasis.
- |||||||||| Review, Journal: Pharmacotherapy for older people with obesity. (Pubmed Central) - Dec 5, 2024
We evaluate in detail the anti-obesity medications currently licenced in Europe, with emphasis on the available efficacy, safety and cardiovascular outcome data gathered from study of older people. Finally, we discuss future directions and avenues of research.
- |||||||||| Journal: Sonography of muscles : Rheumatology-Neurology-Geriatrics-Sports medicine-Orthopedics (Pubmed Central) - Dec 3, 2024
Sonography can ideally be used in addition to magnetic resonance imaging (MRI) in the diagnostics of myositis as it can speed up the diagnosis, muscle groups that were not imaged by MRI can also be assessed sonographically and all muscle groups can be examined during the course of the procedure. Sonography also helps to make a
- |||||||||| Journal: Activation of the apelin/APJ system by vitamin D attenuates age-related muscle atrophy. (Pubmed Central) - Dec 2, 2024
In cirrhotic patients with sarcopenia, an improvement in skeletal muscle and fat mass was observed after PSAE; splenic infarction rate and the L3 SMI before PSAE predicted an improvement in skeletal muscle index in patients with sarcopenia after PSAE. Our present data indicate that vitamin D3 supplementation ameliorates aging-induced muscle atrophy and senescence, similar to the effects of exercise, suggesting the positive impact of vitamin D as an intervention strategy to prevent aging-induced metabolic diseases.
- |||||||||| Journal: Deciphering Osteosarcopenia through the hallmarks of aging. (Pubmed Central) - Dec 2, 2024
The hallmarks of aging provide a theoretical and practical framework that allows for the structured organization of current knowledge and the planning of new development lines. This article comprehensively reviews the currently available literature on the role of the Hallmarks of Aging in the development of osteosarcopenia, thereby offering a panoramic view of the state of the art and knowledge gaps in this field.
- |||||||||| Journal: The role of mitochondria in cytokine and chemokine signalling during ageing. (Pubmed Central) - Dec 2, 2024
In addition, we focus on the dynamic relationship between mitochondrial dysfunction and cellular senescence and its role in regulating the secretion of pro-inflammatory molecules by senescent cells. Finally, we review the existing literature regarding mitochondrial dysfunction and inflammation in specific age-related pathological conditions, including neurodegenerative diseases (Alzheimer's and Parkinson's disease, and amyotrophic lateral sclerosis), osteoarthritis and sarcopenia.
- |||||||||| Review, Journal: The dichotomic role of cytokines in aging. (Pubmed Central) - Dec 2, 2024
In addition, it is discussed the role of the anti-inflammatory cytokine IL-10 and other cytokines that affect aging in a more linear way, such as IL-11, which promotes senescence, and IL-4 and IL-15, which promotes longevity. It is also discussed more specific regulators of aging that are downstream cytokines-mediated signaling.
- |||||||||| Dupixent (dupilumab) / Sanofi, Regeneron, Ohtuvayre (ensifentrine nebulized) / Verona Pharma
Review, Journal: Goals of chronic obstructive pulmonary disease management: a focused review for clinicians. (Pubmed Central) - Dec 2, 2024 The management of COPD continues to evolve with new tools including precision medicine and individualized care. Comorbidities remain important determinants of health, yet their prevalence and impact are underestimated.
- |||||||||| Review, Journal: Exploring the Relationship Between Gut Microbiota and Sarcopenia Based on Gut-Muscle Axis. (Pubmed Central) - Dec 2, 2024
With the continuous deepening of studies, the concept of gut-muscle axis has attracted widespread attention worldwide, and the occurrence and development of sarcopenia are believed to be closely related to the composition and functional alterations of gut microbiota. In this review, combined with existing literatures and clinical reports, we have summarized the role and impacts of gut microbiota on the muscle, the relevance between gut microbiota and sarcopenia, potential mechanisms of gut microbiota in the modulation of sarcopenia, potential methods to alleviate sarcopenia by modulating gut microbiota, and relevant advances and perspectives, thus contributing to adding more novel knowledge to this research direction and providing certain reference for future related studies.
- |||||||||| Retrospective data, Journal: Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis. (Pubmed Central) - Dec 2, 2024
In this review, combined with existing literatures and clinical reports, we have summarized the role and impacts of gut microbiota on the muscle, the relevance between gut microbiota and sarcopenia, potential mechanisms of gut microbiota in the modulation of sarcopenia, potential methods to alleviate sarcopenia by modulating gut microbiota, and relevant advances and perspectives, thus contributing to adding more novel knowledge to this research direction and providing certain reference for future related studies. Sarcopenia is associated with acute biliary infection in patients with HBV-related cirrhosis.
- |||||||||| Review, Journal: Current approach to the diagnosis of sarcopenia in cardiovascular diseases. (Pubmed Central) - Dec 2, 2024
Therefore, screening and diagnosing sarcopenia are particularly important for patients with cardiovascular diseases. This article provides a brief overview of the research progress on diagnostic methods for sarcopenia in patients with cardiovascular diseases.
- |||||||||| Review, Journal: Functional Ingredients Associated with the Prevention and Suppression of Locomotive Syndrome: A Review. (Pubmed Central) - Dec 2, 2024
Therefore, research on the effectiveness of functional ingredients in the prevention and suppression of locomotive syndrome progression is ongoing. In this review, we summarize the latest reports on the effectiveness of five functional ingredients, namely, epigallocatechin gallate, resveratrol, curcumin, ellagic acid, and carnosic acid, in the treatment of osteoarthritis, osteoporosis, and rheumatoid arthritis, which are considered representative diseases of the locomotive syndrome.
|